United States · FDA National Drug Code directory

GABAPENTIN

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
50090-7420_c4b029d0-935e-4fff-87cb-2b615bdf0903
Product NDC
50090-7420
Form
CAPSULE
Composition / generic term
gabapentin
Labeler
A-S Medication Solutions
Marketing category
ANDA
Marketing start / end (source format)
20210510
Source listing expiry
20271231

Source-listed ingredients

  • GABAPENTIN — 300 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 100 CAPSULE in 1 BOTTLE (50090-7420-0) · 50090-7420-0
  • 30 CAPSULE in 1 BOTTLE (50090-7420-1) · 50090-7420-1
  • 60 CAPSULE in 1 BOTTLE (50090-7420-2) · 50090-7420-2
  • 120 CAPSULE in 1 BOTTLE (50090-7420-3) · 50090-7420-3
  • 90 CAPSULE in 1 BOTTLE (50090-7420-4) · 50090-7420-4
  • 240 CAPSULE in 1 BOTTLE (50090-7420-5) · 50090-7420-5
  • 270 CAPSULE in 1 BOTTLE (50090-7420-6) · 50090-7420-6
  • 42 CAPSULE in 1 BOTTLE (50090-7420-8) · 50090-7420-8
  • 14 CAPSULE in 1 BOTTLE (50090-7420-9) · 50090-7420-9

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →